CL (Colgate-Palmolive Co) Change In Receivables : $22 Mil (TTM As of Mar. 2025)

View and export this data going back to 1951. Start your Free Trial

What is Colgate-Palmolive Co Change In Receivables?

Colgate-Palmolive Co's change in receivables for the quarter that ended in Mar. 2025 was $-174 Mil. It means Colgate-Palmolive Co's Accounts Receivable increased by $174 Mil from Dec. 2024 to Mar. 2025 .

Colgate-Palmolive Co's change in receivables for the fiscal year that ended in Dec. 2024 was $-56 Mil. It means Colgate-Palmolive Co's Accounts Receivable increased by $56 Mil from Dec. 2023 to Dec. 2024 .

Colgate-Palmolive Co's Accounts Receivable for the quarter that ended in Mar. 2025 was $1,725 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Colgate-Palmolive Co's Days Sales Outstanding for the three months ended in Mar. 2025 was 32.05.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Colgate-Palmolive Co's liquidation value for the three months ended in Mar. 2025 was $-12,446 Mil.

Colgate-Palmolive Co Change In Receivables Historical Data

The historical data trend for Colgate-Palmolive Co's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Colgate-Palmolive Co Change In Receivables Chart

Colgate-Palmolive Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Change In Receivables

Get a 7-Day Free Trial

138.00

-84.00

-227.00

-37.00

-56.00

Colgate-Palmolive Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Change In Receivables	Get a 7-Day Free Trial															-252.00	-57.00	125.00	128.00	-174.00

Colgate-Palmolive Co Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $22 Mil.

Colgate-Palmolive Co (NYSE:CL) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Colgate-Palmolive Co's Days Sales Outstanding for the quarter that ended in Mar. 2025 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	1725	/	4911	*	91
=	32.05

2. In Ben Graham's calculation of liquidation value, Colgate-Palmolive Co's accounts receivable are only considered to be worth 75% of book value:

Colgate-Palmolive Co's liquidation value for the quarter that ended in Mar. 2025 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	1112	-	15914	+	0.75 * 1725	+	0.5 * 2125
=	-12,446

Colgate-Palmolive Co Change In Receivables Related Terms

Thank you for viewing the detailed overview of Colgate-Palmolive Co's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Colgate-Palmolive Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Colgate-Palmolive Co (NYSE:CL) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

CL:Mexico 1CL:Italy CPAd:UK 0P59:UK CPA:Germany CPA:Germany CPA:Germany CPA:Germany COLG34:Brazil COLG:Austria CL:Argentina

Address

300 Park Avenue, New York, NY, USA, 10022

Website

https://www.colgatepalmolive.com

Since its founding in 1806, Colgate-Palmolive has grown to become a leading player in the household and personal care arena. In addition to its namesake oral care line (which accounts for north of 40% of its total sales), the firm manufactures shampoos, shower gels, deodorants, and homecare products that are sold in over 200 countries. International sales account for about 70% of its total business, including approximately 45% from emerging regions. It also owns specialty pet food maker Hill's (around one fifth of sales), which sells a majority of its products through veterinarians and specialty pet retailers.

Executives

Sally Massey	officer: Chief Human Resources Officer	300 PARK AVENUE, NEW YORK NY 10022
Gregory Malcolm	officer: Vice President and Controller	300 PARK AVENUE, NEW YORK NY 10022
Noel R. Wallace	officer: Pres.- Colgate No. America	C/O COLGATE-PALMOLIVE COMPANY, 300 PARK AVENUE, NEW YORK NY 10022
Sutula Stanley J Iii	officer: Chief Financial Officer	IBM CORPORATION, ONE NEW ORCHARD ROAD, ARMONK NY 10504
Panagiotis Tsourapas	officer: Pres., Colgate-Africa/Eurasia	C/O COLGATE-PALMOLIVE COMPANY, 300 PARK AVENUE, NEW YORK NY 10022
Martina Hundmejean	director	C/O TYCO INTERNATIONAL (US) INC, 9 WEST 57TH ST 43RD FL., NEW YORK NY 10019
Jennifer Daniels	officer: CLO and Secretary	C/O BARNES & NOBLE, INC., 122 FIFTH AVENUE, NEW YORK NY 10011
John W Kooyman	officer: Chief Marketing Officer	300 PARK AVENUE, NEW YORK NY 10022
John P Bilbrey	director
John T Cahill	director	LEGG MASON, INC., 100 INTERNATIONAL DRIVE, BALTIMORE MD 21202
Lorrie M Norrington	director	C/O EBAY INC., 2145 HAMILTON AVENUE, SAN JOSE CA 95125
Prabha Parameswaran	officer: Grp Pres, Glbl Innov. & AF/Eus	300 PARK AVENUE, NEW YORK NY 10022
Stephen I Sadove	director
C Martin Harris	director
Steven A Cahillane	director	ONE COCA-COLA PLAZA, ATLANTA GA 30313